Simon Sands on Spoutible

“Today’s action is the first verification that a drug targeting the underlying disease process of Alzheimer’s disease has shown clinical benefit in this devastating disease,” Teresa Buracchio, acting director of the Office of Neuroscience in the FDA’s Center for Drug Evaluation and Research, said in

cnn.com

First Alzheimer’s drug to slow disease progression gets full FDA approval, triggering broader Medicare coverage | CNN

The US Food and Drug Administration on Thursday granted full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the disease.

06:18 PM - Jul 06, 2023

Send reset password code via:

Enter the code to update your password.

Reset Your Password

Sign In

First Alzheimer’s drug to slow disease progression gets full FDA approval, triggering broader Medicare coverage | CNN